1. Evaluations of thyme extract effects in human normal bronchial and tracheal epithelial cell lines and in human lung cancer cell line
- Author
-
Santoni Giorgio, Nabissi Massimo, Nicotra Giovanna, Morelli Maria Beatrice, Iannarelli Romilde, Cardinali Claudio, Maggi Filippo, Amantini Consuelo, Valisi Matteo, and Marinelli Oliviero
- Subjects
0301 basic medicine ,Lung Neoplasms ,medicine.drug_class ,Interleukin-1beta ,Anti-Inflammatory Agents ,Bronchi ,Inflammation ,Respiratory Mucosa ,Pharmacology ,Toxicology ,Anti-inflammatory ,Cell Line ,Thymus Plant ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,medicine ,Humans ,Interleukin 8 ,Lung ,Thymol ,Cell Death ,Plant Extracts ,business.industry ,Interleukin-8 ,NF-kappa B ,General Medicine ,respiratory system ,Antineoplastic Agents, Phytogenic ,Mucus ,respiratory tract diseases ,Trachea ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Cancer cell ,Immunology ,medicine.symptom ,business - Abstract
Thyme (Thymus vulgaris) is used traditionally to prepare herbal remedies possessing expectorant, mucolytic, antitussive and antispasmodic properties. The aim of the present study was to investigate the effects of a standardized hydroalcoholic extract of thyme on primary human airway (bronchial/tracheal) epithelial cell lines in a model of lung inflammation induced by LPS. In addition, the effects of thyme extract on human lung cancer cell line (H460) were analysed. Thyme extract showed significant anti-inflammatory properties by reducing the NF-κB p65 and NF-κB p52 transcription factors protein levels followed by the decrease of pro-inflammatory cytokines (IL-1 beta and IL-8), and Muc5ac secretion in human normal bronchial and tracheal epithelial cells. Moreover, the extract showed cytotoxic effects on H460 cancer cells, modulated the release of IL-1 beta, IL-8 and down-regulated NF-κB p65 and NF-κB p52 proteins. Taken together, these results substantiated the traditional uses of thyme in the treatment of respiratory diseases. Thyme extract might be an effective treatment of chronic diseases based on inflammatory processes when hypersecretion of mucus overwhelms the ciliary clearance and obstructs airways, causing morbidity and mortality. Moreover thyme extract, evaluated in H460 lung cancer cell line, demonstrated to induce cell cytotoxicity in addition to reduce inflammatory cell signals.
- Published
- 2016
- Full Text
- View/download PDF